Middle East
A. Menarini Gets European Rights to Nucleix Bladder Cancer Test
The CE-marked and FDA-cleared test analyzes disease-specific changes in 15 DNA methylation markers in urine using qPCR.
Centogene Delisted From Nasdaq
The German rare disease company expects its common stock to begin trading on the OTC Markets Group platform on Aug. 8 under the ticker symbol CNTGF.
The company’s research-use-only AmplideX Nanopore Carrier Plus kit can interrogate 11 genes underpinning nine common carrier screening conditions.
Caris Life Sciences, Juniper Biologics Expand Solid Tumor Profiling Distribution Deal
The deal expands the previous agreement, granting Juniper exclusive distribution rights throughout Africa and the Middle East.
Salignostics, Sheba Medical Center Partner on Saliva-Based Oral Cancer Test
If the initial collaboration is successful, the partners aim to expand their work to include other malignancies including head and neck cancer.